In humans, a repeat polymorphism in the promoter region of the prostacyclin synthase gene was found to reduce prostacyclin synthase transcription and to be associated with increased odds of hypertension (Iwai et al., 1999). The gene discussed is PTGIS; the disease is hypertensive disorder.